TenderFinder

CSL BEHRING (AUSTRALIA) PTY LTD

ABN 48160734761

Also recorded as CSL Behring (Australia) Pty Ltd.

Total awarded

$5.78B

Contracts

11

Agencies

2

Annual run-rate

$723.3M

Steady. Annualised run-rate over the last four complete quarters is broadly level against the four quarters before it.

Contract value over time

CSL BEHRING (AUSTRALIA) PTY LTD annualised contract run-rate by quarterAnnualised run-rate spreads each contract's value evenly across its term, so a multi-year renewal does not read as a spike in growth. Switch to raw award value to see the value booked on the day each contract was signed. Quarters past the last complete one are work already under contract, not a forecast.already contracted$0$50.0M$100.0M$150.0M$200.0M2016201720182019202020212022202320242025202620272028CSL BEHRING (AUSTRALI...

Annualised run-rate spreads each contract's value evenly across its term, so a multi-year renewal does not read as a spike in growth. Switch to raw award value to see the value booked on the day each contract was signed. Quarters past the last complete one are work already under contract, not a forecast.

What they supply

Product or service areaValueContractsShare
Comprehensive health services$3.56B461.6%
Drugs and Pharmaceutical Products$2.22B738.4%

Who buys from them

National Blood Authority$5.78B
Department of Defence$54K

Ending in the next 12 months

$3.63B of contracted work reaches its end date. See everything ending soon.

  • National Fractionation AgreementNational Blood Authority · ends 2026-12-30$3.35B
  • Imported Plasma and Recombinant ProductsNational Blood Authority · ends 2027-06-29$271.3M
  • Imported Plasma and Recombinant Products (Factor XI Concentrate)National Blood Authority · ends 2027-06-29$8.3M

How they win work

1.3% of this supplier's contract value was won through open tender. A low figure means most work is awarded through limited tender, which usually signals an entrenched incumbent.

Recent contracts

  • Pharmaceutical ProductsDepartment of Defence · 2026-04-28$23KAusTender
  • Pathology ProductsDepartment of Defence · 2026-04-20$10KAusTender
  • Pathology ProductsDepartment of Defence · 2025-10-13$10KAusTender
  • Pathology ProductsDepartment of Defence · 2025-09-24$10KAusTender
  • Procurement of Imported Plasma and Recombinant Products (IPRP) - IdelvionNational Blood Authority · 2025-07-18$73.6MAusTender
  • Imported Plasma and Recombinant ProductsNational Blood Authority · 2022-11-02$271.3MAusTender
  • Imported Plasma and Recombinant Products (Factor XI Concentrate)National Blood Authority · 2022-11-02$8.3MAusTender
  • National Supply arrangement for imported immunoglobulin productsNational Blood Authority · 2021-01-19$1.87BAusTender
  • National Fractionation AgreementNational Blood Authority · 2018-01-10$3.35BAusTender
  • Supply of Imported Plasma and Recombinant ProductsNational Blood Authority · 2016-12-14$6.5MAusTender
  • Supply of Imported Plasma and Recombinant Products (IPRP)National Blood Authority · 2016-10-25$190.5MAusTender

Compare with similar suppliers

CSL vs BUPA HEALTH SERVICES PTY LTDCSL vs Seqirus (Australia) Pty LtdCSL vs GlaxoSmithKline Australia Pty LtdCSL vs ASPEN MEDICAL PTY LIMITEDCSL vs SAAB AUSTRALIA PTY LTD

Get told when work like this comes up for renewal

We will email you when contracts in the same area as CSL BEHRING (AUSTRALIA) PTY LTD approach their end date, so you can position before the replacement goes to market. Free, and you can unsubscribe from any email.

Federal contracts only. This is published AusTender data for Commonwealth agencies. It does not include state or territory contracts.

Figures are calculated from published AusTender contract notices. Verify on AusTender.

Last recalculated 2026-07-30.